Table 1 Baseline characteristics of study population (N = 74 cases)
Baseline characteristics | N (%) or mean ± SD |
|---|---|
Age | 49.38 ± 15.70 |
Female | 62 (83.8) |
Underlying disease | |
Rheumatoid arthritis | 16 (21.6) |
Systemic lupus erythematosus | 18 (24.3) |
Adult-onset immunodeficiency with anti-IFN-gamma autoantibody | 9 (12.2) |
Pemphigus vulgaris | 8 (10.8) |
Sjogren’s syndrome | 5 (6.8) |
Inflammatory myopathy | 5 (6.8) |
IgG4-related disease | 2 (2.7) |
Focal segmental glomerulosclerosis | 1 (1.4) |
Systemic sclerosis | 2 (2.7) |
Neuromyelitis optica | 1 (1.4) |
Granulomatosis with polyangiitis | 5 (6.8) |
Overlapping syndrome | 2 (2.7) |
RA + SLE | 1 (1.4) |
RA + Sjogren’s syndrome | 1 (1.4) |
Concomitant medications | |
Prednisolone | 51 (68.9) |
Antimalarial agent | 31 (41.9) |
Methotrexate | 20 (27.0) |
Azathioprine | 16 (21.6) |
Cyclophosphamide | 16 (21.6) |
Cyclosporine | 8 (10.8) |
Mycophenolate mofetil | 10 (13.5) |
Leflunomide | 10 (13.5) |
Sulfasalazine | 5 (6.8) |
Chlorambucil | 2 (2.7) |
Dexamethasone | 2 (2.7) |
Tacrolimus | 1 (1.4) |
Intravenous immunoglobulin | 1 (1.4) |